Avidity Biosciences Inc (RNA)
25.57
-0.23
(-0.89%)
USD |
NASDAQ |
May 02, 16:00
25.57
0.00 (0.00%)
After-Hours: 18:32
Avidity Biosciences Cash from Financing (Quarterly): 31.89M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 31.89M |
| September 30, 2023 | 0.04M |
| June 30, 2023 | 38.97M |
| March 31, 2023 | 22.96M |
| December 31, 2022 | 243.65M |
| September 30, 2022 | 39.62M |
| June 30, 2022 | 38.78M |
| March 31, 2022 | 24.11M |
| December 31, 2021 | 20.71M |
| September 30, 2021 | 155.17M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.413M |
| March 31, 2021 | 0.017M |
| December 31, 2020 | 0.45M |
| September 30, 2020 | -1.346M |
| June 30, 2020 | 271.61M |
| March 31, 2020 | 1.323M |
| December 31, 2019 | 71.82M |
| September 30, 2019 | -0.712M |
| June 30, 2019 | 14.30M |
| March 31, 2019 | 3.822M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.346M
Minimum
Sep 2020
271.61M
Maximum
Jun 2020
51.25M
Average
22.96M
Median
Mar 2023
Cash from Financing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | -50.90M |
| Codexis Inc | 0.00 |
| HOOKIPA Pharma Inc | 21.25M |
| DocGo Inc | 12.98M |
| Kineta Inc | 2.246M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 16.50M |
| Cash from Investing (Quarterly) | 51.04M |
| Free Cash Flow | -123.29M |
| Free Cash Flow Per Share (Quarterly) | 0.2055 |
| Free Cash Flow to Equity (Quarterly) | 15.64M |
| Free Cash Flow Yield | -6.60% |